ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
0.00%
Dow Jones
37,903.29
0.00%
US Dollar vs MXN
16.93056
-0.08%
Brent Oil
83.775
0.28%
Bitcoin
58,878.72
1.10%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. West Pharmaceutical Services Inc (WST)

  7. West Pharmaceutical Services Inc (WST) Noticias

WST West Pharmaceutical Services Inc

363.43
0.00 (0.00%)
Pre Mercado
Última actualización: 07:31:50
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
West Pharmaceutical Services Inc WST NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 363.43 07:31:50
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
363.43
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202405:00PRNUSWest to Participate in Upcoming Investor Conference
25/4/202405:00PRNUSWest Announces First-Quarter 2024 Results and Declares..
11/4/202405:00PRNUSWest to Host First-Quarter 2024 Conference Call
01/3/202415:24EDGAR2Form PRE 14A - Other preliminary proxy statements
01/3/202412:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:30PRNUSWest to Participate in Upcoming Investor Conferences
27/2/202415:23EDGAR2Form 144 - Report of proposed sale of securities
27/2/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:44EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202405:00PRNUSWest Announces Second-Quarter 2024 Dividend
15/2/202406:51EDGAR2Form 8-K - Current report
15/2/202405:00PRNUSWest Announces Fourth-Quarter and Full-Year 2023 Results
07/2/202407:00PRNUSWest Named to Newsweek's America's Greatest Workplaces 2024..
01/2/202405:00PRNUSWest to Host Fourth-Quarter and Full-Year 2023 Conference..
24/1/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/12/202311:54EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
13/12/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202314:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202305:00PRNUSWest Announces First-Quarter 2024 Dividend
05/12/202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:46DJNWest Gets FDA 510(k) Clearance for Vial2Bag Advanced 13mm..
04/12/202314:00PRNUSWest Receives FDA 510(k) Clearance for Vial2Bag Advanced®..
30/11/202315:05EDGAR2Form 8-K - Current report
13/11/202306:00GLOBESotera Health Appoints Karen Flynn to Board of Directors
02/11/202312:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202305:00PRNUSWest to Participate in Upcoming Investor Conferences
26/10/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202306:41EDGAR2Form 8-K - Current report
26/10/202305:00PRNUSWest Announces Third-Quarter 2023 Results, Updates Full-Year..
23/10/202305:00PRNUSWest to Attend and Showcase Industry Leadership in Packaging..
16/10/202305:00PRNUSWest to Present on Development of Large Volume Delivery..
12/10/202305:00PRNUSWest to Host Third-Quarter 2023 Conference Call
21/9/202315:33EDGAR2Form 8-K/A - Current report: [Amend]
07/9/202305:00PRNUSWest to Participate in Upcoming Investor Conference
01/9/202314:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202318:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202313:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202313:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NYSE
WST
West Pharmaceutical Serv...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados